HHS Price Negotiation Under Medicare Rx Would Not Beat PBM Prices – CMS

HHS price negotiations for the Medicare drug benefit would not yield greater savings than health plans will be able to secure because the government would be unlikely to use its negotiating power forcefully enough, Centers for Medicare & Medicaid Services Chief Actuary Richard Foster says